A Metagenomic β-glucuronidase Uncovers a Core Adaptive Function of the Human Intestinal Microbiome
Overview
Affiliations
In the human gastrointestinal tract, bacterial β-D-glucuronidases (BG; E.C. 3.2.1.31) are involved both in xenobiotic metabolism and in some of the beneficial effects of dietary compounds. Despite their biological significance, investigations are hampered by the fact that only a few BGs have so far been studied. A functional metagenomic approach was therefore performed on intestinal metagenomic libraries using chromogenic glucuronides as probes. Using this strategy, 19 positive metagenomic clones were identified but only one exhibited strong β-D-glucuronidase activity when subcloned into an expression vector. The cloned gene encoded a β-D-glucuronidase (called H11G11-BG) that had distant amino acid sequence homologies and an additional C terminus domain compared with known β-D-glucuronidases. Fifteen homologs were identified in public bacterial genome databases (38-57% identity with H11G11-BG) in the Firmicutes phylum. The genomes identified derived from strains from Ruminococcaceae, Lachnospiraceae, and Clostridiaceae. The genetic context diversity, with closely related symporters and gene duplication, argued for functional diversity and contribution to adaptive mechanisms. In contrast to the previously known β-D-glucuronidases, this previously undescribed type was present in the published microbiome of each healthy adult/child investigated (n = 11) and was specific to the human gut ecosystem. In conclusion, our functional metagenomic approach revealed a class of BGs that may be part of a functional core specifically evolved to adapt to the human gut environment with major health implications. We propose consensus motifs for this unique Firmicutes β-D-glucuronidase subfamily and for the glycosyl hydrolase family 2.
The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma.
Yao J, Ning B, Ding J Gut Microbes. 2025; 17(1):2473504.
PMID: 40042184 PMC: 11901387. DOI: 10.1080/19490976.2025.2473504.
Causality between gut microbiota, immune cells, and breast cancer: Mendelian randomization analysis.
Lv R, Wang D, Wang T, Li R, Zhuang A Medicine (Baltimore). 2024; 103(49):e40815.
PMID: 39654239 PMC: 11630993. DOI: 10.1097/MD.0000000000040815.
Su H, Yang S, Chen S, Chen X, Guo M, Zhu L Int J Mol Sci. 2024; 25(16).
PMID: 39201270 PMC: 11354725. DOI: 10.3390/ijms25168582.
From Gut Microbiomes to Infectious Pathogens: Neurological Disease Game Changers.
K M M, Ghosh P, Nagappan K, Palaniswamy D, Begum R, Islam M Mol Neurobiol. 2024; 62(1):1184-1204.
PMID: 38967904 DOI: 10.1007/s12035-024-04323-0.
Cuffaro F, Russo E, Amedei A Int J Mol Sci. 2024; 25(12).
PMID: 38928175 PMC: 11203696. DOI: 10.3390/ijms25126473.